As of 2026-04-29, the Relative Valuation of Biovaxys Technology Corp (BIOV.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 CAD, the upside of Biovaxys Technology Corp based on Relative Valuation is -117.1%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -113.7% - -120.6% | -117.1% |
| Date | P/E |
| 2026-04-27 | -0.29 |
| 2026-04-24 | -0.21 |
| 2026-04-23 | -0.17 |
| 2026-04-22 | -0.17 |
| 2026-04-21 | -0.17 |
| 2026-04-20 | -0.21 |
| 2026-04-17 | -0.21 |
| 2026-04-16 | -0.23 |
| 2026-04-15 | -0.23 |
| 2026-04-14 | -0.23 |
| 2026-04-13 | -0.21 |
| 2026-04-10 | -0.23 |
| 2026-04-09 | -0.25 |
| 2026-04-08 | -0.27 |
| 2026-04-07 | -0.27 |
| 2026-04-06 | -0.27 |
| 2026-04-02 | -0.27 |
| 2026-04-01 | -0.29 |
| 2026-03-31 | -0.31 |
| 2026-03-30 | -0.31 |
| 2026-03-27 | -0.38 |
| 2026-03-25 | -0.38 |
| 2026-03-24 | -0.35 |
| 2026-03-23 | -0.38 |
| 2026-03-20 | -0.33 |
| 2026-03-19 | -0.33 |
| 2026-03-18 | -0.38 |
| 2026-03-17 | -0.38 |
| 2026-03-16 | -0.33 |
| 2026-03-13 | -0.40 |
| 2026-03-12 | -0.42 |
| 2026-03-11 | -0.42 |
| 2026-03-10 | -0.40 |
| 2026-03-09 | -0.40 |
| 2026-03-06 | -0.42 |
| 2026-03-05 | -0.44 |
| 2026-03-04 | -0.50 |
| 2026-03-03 | -0.54 |
| 2026-03-02 | -0.60 |
| 2026-02-27 | -0.65 |
| 2026-02-26 | -0.65 |
| 2026-02-25 | -0.65 |
| 2026-02-24 | -0.58 |
| 2026-02-23 | -0.54 |
| 2026-02-20 | -0.54 |
| 2026-02-19 | -0.50 |
| 2026-02-18 | -0.48 |
| 2026-02-17 | -0.52 |
| 2026-02-13 | -0.48 |
| 2026-02-12 | -0.50 |